HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors.

导出 OA

翻译打印收藏纠错

作者： Olga,Martinho ^[1] ; Renato,Silva-Oliveira ^[2] ; Fernanda P,Cury ^[2] ; Ana Martins,Barbosa ^[3] ; Sara,Granja ^[3] ; Adriane Feijó,Evangelista ^[2] ; Fábio,Marques ^[4] ; Vera,Miranda-Gonçalves ^[3] ; Diana,Cardoso-Carneiro ^[3] ; Flávia E,de Paula ^[2] ; Maicon,Zanon ^[2] ; Cristovam,Scapulatempo-Neto ^[2] ; Marise A R,Moreira ^[4] ; Fátima,Baltazar ^[3] ; Adhemar,Longatto-Filho ^[5] ; Rui Manuel,Reis ^[1]

作者单位： Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal;; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal;; Molecular Oncology Research Center (CPOM), Barretos Cancer Hospital, Barretos, São Paulo, Brazil. ^[1] Molecular Oncology Research Center (CPOM), Barretos Cancer Hospital, Barretos, São Paulo, Brazil. ^[2] Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal;; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal. ^[3] Department of Pathology of the School of Medicine of the Federal University of Goiás, Brazil. ^[4] Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal;; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal;; Molecular Oncology Research Center (CPOM), Barretos Cancer Hospital, Barretos, São Paulo, Brazil;; Laboratory of Medical Investigation (LIM) 14, Faculty of Medicine, São Paulo State University, Brazil. ^[5]

关键词 EGFR ErbB HER2 cervical cancer prognosis targeted therapy.